Skip to main content

Antipodes Partners Ltd

SEC CIK
0001652442
Latest filing
Aug 6, 2026

SPRY holding history

ARS Pharmaceuticals, Inc. in every 13F filed by Antipodes Partners Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SPRY overviewAll 13F holders of SPRYFull Q2 2026 holdings

Shares (Q3 2025)
0
Sold out in Q3 2025
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q1 2025
Holdings of SPRY by Antipodes Partners Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q3 20250$00.0%−2,201−100.0%Sold outHolders
Q2 20252,201$38.4K<0.1%−742−25.2%ReducedHolders
Q1 20252,943$37.0K<0.1%+2,943NewHolders